Since 2014, when compumedics turned to become a profitable...

Since 2014, when compumedics turned to become a profitable business, it signals the firm's ability to maintain profitability, in face of significant R&D expense, about 5 millions per year (15% of its revenue).

To illustrate the R&D expense, CMP's profit was about 1 million in 2014, its R&D is 5 times as much.

Now, commercialization stage is approaching, probably within a year from now.  R&D finally started to pay off and give CMP plenty of product pipelines, mainly in eHealth, driver fatigue system, as well as stroke/brain trauma management from its DWL division and Somfit.


1. eHealth : already signed contract with health providers to develop ehealth system. More solid announcement should be made during the rest of 2015.

2. driver fatigue system : "working on the final stages to validate the algorithms before their hybrid detector is marketed for production"
http://www.smh.com.au/national/how-to-alert-drivers-to-fatigue-20150420-1mlyp9.html

3. stroke/trauma management: TBA

4. Somfit: medical wearable device, featured in CES. Marketing/production should come online in 2015.

With so many product pipelines, it would probably be the best, if CMP  undertakes most of marketing/manufacturing with strategic partners. The best way for CMP to leverage its technology edge is to license its technology/design, so it could focus on developing its technology competitive advantage with similar business model to Apple/Google/tech firm.